[144] Medpace Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Form 4 filing overview: On 07/25/2025 BlackLine (BL) director Gregory Hughes received an initial award of 2,976 restricted stock units (RSUs) granted under the Outside Director Compensation Policy. Each RSU equals one common share.

Vesting: 100 % of the RSUs vest the day prior to the next annual shareholder meeting, conditioned on Mr. Hughes’ continued board service. The grant was acquired at $0 cost; no shares were sold or disposed.

Post-transaction holdings: Hughes now beneficially owns 2,976 BL shares, all held directly. No derivative securities are reported.

Investor take-away: This is a routine director onboarding equity grant that slightly increases insider ownership and has immaterial dilution given BlackLine’s ~59 m shares outstanding. No performance metrics or other material events accompany the filing.

Insights

Corporate Governance Analyst

TL;DR: Routine RSU grant; modest size, neutral impact, signals standard director-shareholder alignment.

The 2,976-share RSU award is typical compensation for new BL board members. Because the grant is time-based and represents less than 0.01 % of outstanding shares, dilution risk is negligible. No purchases or sales were made, so the filing provides limited insight into insider sentiment beyond ordinary alignment incentives. Overall market impact should be neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	356446	161001311	28741609	07/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/07/2025	NQ Options Exercise	Issuer			356446	03/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)